« Previous
Next »
American Journal of Otolaryngology - Head and Neck Medicine and Surgery
Volume 30, Issue 5
, Pages
305-311
, September 2009
Quality of life outcomes with sublingual immunotherapy
To access this article, please choose from the options below
☆ Presented at the spring meeting of the American Rhinologic Society, San Diego, CA, April 27, 2007.
☆☆ Dr Wise has received grant support from XoranTech, Inc., Ann Arbor, MI; Acclarent, Inc., Menlo Park, CA; NeilMed Pharmaceuticals, Inc., Santa Rosa, CA; Flight Attendants Medical Research Institute, Miami, FL; and Cystic Fibrosis Foundation, Bethesda, MD. Dr. Schlosser is a consultant or advisor for BrainLAB, Inc., Westchester, IL; Gyrus ACMI, Inc., Southborough, MA; Medtronic, Inc., Jacksonville, FL; and Schering Plough, Kenilworth, NJ. Dr Schlosser is on the speaker's bureau for GlaxoSmithKline, Brentford, Middlesex, UK. Ms Woody and Ms Koepp have no financial interests to declare. None of the above-noted financial interests had a direct impact on the design, data collection, data analysis, or interpretation performed in this study.
★ Approval for this study was granted by the Institutional Review Board of the Medical University of South Carolina HR16707, (Charleston, SC).
PII: S0196-0709(08)00116-6
doi: 10.1016/j.amjoto.2008.06.003
© 2009 Elsevier Inc. All rights reserved.
« Previous
Next »
American Journal of Otolaryngology - Head and Neck Medicine and Surgery
Volume 30, Issue 5
, Pages
305-311
, September 2009
